Literature DB >> 4100922

Hodgkin's disease: remissions after measles.

Z Zygiert.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 4100922     DOI： 10.1016/s0140-6736(71)91186-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  36 in total

1.  Infantile Hodgkin's disease: remission after measles.

Authors:  H C Mota
Journal:  Br Med J       Date:  1973-05-19

Review 2.  Attenuated oncolytic measles virus strains as cancer therapeutics.

Authors:  P Msaouel; I D Iankov; A Dispenzieri; E Galanis
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

3.  Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials.

Authors:  A D Hartkopf; T Fehm; M Wallwiener; U Lauer
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-02       Impact factor: 2.915

Review 4.  An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.

Authors:  Seung Min Bang; June Won Cheong; Woo Ick Yang; Jee Sook Hahn
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

Review 5.  Oncolytic measles virus strains as novel anticancer agents.

Authors:  Pavlos Msaouel; Mateusz Opyrchal; Evidio Domingo Musibay; Evanthia Galanis
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

6.  MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.

Authors:  Hirosha Geekiyanage; Evanthia Galanis
Journal:  Mol Oncol       Date:  2016-07-28       Impact factor: 6.603

Review 7.  Measles virus for cancer therapy.

Authors:  S J Russell; K W Peng
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

8.  Picornavirus infection leading to immunosuppression.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2014-05-01       Impact factor: 1.831

9.  Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy.

Authors:  Tanner S Miest; Marie Frenzke; Roberto Cattaneo
Journal:  Mol Ther       Date:  2013-08-05       Impact factor: 11.454

Review 10.  Relevance of the Measles Virus Expression in Cancer - an Update.

Authors:  Daniel Benharroch; Samuel Ariad; Noa Tadmor; Karen Nalbandyan; Irena Lazarev
Journal:  Pathol Oncol Res       Date:  2016-06-10       Impact factor: 3.201
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.